Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool May 9, 2005 Jim Schoettler	Be Like Buffett Learn how Warren Buffett melded others' investment styles into his own winning approach and how this can work for you, too.
The Motley Fool January 26, 2005 Rich Duprey	Chiron's Earnings Ills Flu vaccine manufacturer expected to report significantly lower profits.
The Motley Fool September 14, 2007 Sham Gad	Buffett's Words of Wisdom Want to become a better investor? Do what Warren would do: Invest in great businesses that you understand, and then be patient.
The Motley Fool June 17, 2005 W.D. Crotty	Biotech's Apple Dumpling Gang Chiron has made a number of financial and planning mistakes in the production of its flu vaccine.
The Motley Fool September 13, 2005 Tim Hanson	The Virtues of Value No matter what kind of investor you are, you'll benefit by buying bargains. The secret to successful investing is simple: Buy low, sell high. Every investor would do well to learn that mantra.
The Motley Fool August 10, 2010 Mac Greer	Buffett Doesn't Just Buy Cheap Stocks Exploding a myth.
The Motley Fool March 9, 2005 Brian Richards	The Bargain Hunter Value investments lurk in any market. The trick is knowing how to find them.
The Motley Fool June 14, 2005 Rich Duprey	Chiron's Credit Conundrum Standard & Poor's downgrades the biotech's credit rating on seemingly old news. Why now?
The Motley Fool January 28, 2005 Philip Durell	Tom Gardner Interviews Philip Durell Tom and the author get together to talk value investing.
The Motley Fool October 6, 2004 Rich Duprey	Chiron Sneezes, Investors Catch Cold British authorities shut down the pharmaceutical's only U.S. flu vaccine manufacturing facility. This may in fact be an opportunity to scoop up a beleaguered stock at fire sale prices.
The Motley Fool October 18, 2006 Chuck Saletta	Your Edge Over Buffett With less competition chasing a larger pool of great potential investments, you've got a far better chance of finding and buying great stocks.
The Motley Fool March 16, 2006 Rich Duprey	Chiron's Shareholder Revolt Hedge funds oppose the biotech's buyout by pharmaceutical giant Novartis. Investors, take note.
The Motley Fool October 18, 2005 Rich Duprey	Chiron's Sickly Forecast The flu vaccine maker further reduces its estimated dose production. With its earnings release due next week, perhaps Chiron was simply preparing investors for a jolt.
The Motley Fool July 27, 2005 Tim Hanson	Join the Investor's Pantheon Understanding history's greatest investors can help you identify the best the market has to offer. Master investors Graham, Buffett, and Lynch were successful for a reason. Know their secrets ... and take the next step.
The Motley Fool September 21, 2005 Rich Duprey	A Shot of Reality for Chiron Novartis warns pharma it's willing to walk away from takeover bid. Does Chiron have the wherewithal to go it alone? Investors, take note.
BusinessWeek January 31, 2005 Arlene Weintraub	Chiron's Flu Aches May Last Awhile Its vaccine rivals are gaining traction -- and its other businesses are just so-so
The Motley Fool August 14, 2006	Meet Benjamin Graham Many investors hold Warren Buffett, arguably America's greatest investor, in the highest esteem, and rightfully so. But whom might you find on Warren's own pedestal?
The Motley Fool October 21, 2008 Bill Mann	Is Buffett Talking Up His Own Book? Reflecting on columnist David Weidner's article about Warren Buffett on Marketwatch.com.
The Motley Fool March 9, 2005 Rich Duprey	Chiron Bundles Bad News The flu vaccine maker's bad news bonanza can't mask that it's overvalued.
The Motley Fool January 26, 2005 Richard Gibbons	How to Outperform in 2005 Here are five tips to help investors identify stocks that are set to trounce the market.
The Motley Fool July 28, 2006 Tim Beyers	Meet the Value Investor Often, you'll hear that there are two types of investors, value and growth. The truth is there isn't much difference.
The Motley Fool April 30, 2008 Brian Richards	Roundtable: Buffett's Next Moves, and Is Berkshire a Buy? Several analysts discuss what they would ask William Buffett if they could.
The Motley Fool October 20, 2005 Seth Jayson	Buffett's Stealth Values Enterprises can often be on sale not because there's anything wrong with them, but because Wall Street has forgotten them, even though their signs and products may be on every Main Street or store shelf in America.
The Motley Fool December 3, 2009 Nick Kapur	Warren Buffett Is Breaking the Rules! The Oracle is making big bets. Are you? For a guy who claims his first rule of investing is "Never lose money," Warren Buffett doesn't appear to have much of a problem with it.
The Motley Fool December 15, 2009 Jim Royal	What's Next on Warren Buffett's Buy List? It has been shown that investors who simply copied Warren Buffett's investments would have earned an average 24.6% annually for 30 years through 2006.
The Motley Fool August 12, 2004 Tom Gardner	3 Tools for Small-Cap Success Here are tips to track long-range trends.
The Motley Fool November 13, 2007 Sham Gad	The Art of Selling High You can buy low, but if you don't know the fair value of a company, and when to sell, your success will hinge on luck.
The Motley Fool September 7, 2005 Rich Duprey	Is Chiron Worth It? The vaccine maker rejects Novartis' bid of $40 a share as inadequate. How much should the pharma pay? Investors, take note.
Salon.com August 31, 1999 Larry Kanter	Warren Buffett The Oracle of Omaha -- the world's greatest stock market investor -- lives in a house he bought for $31,500, dines on burgers and quotes Mae West. He's worth $36 billion ... give or take a few mil.
The Motley Fool April 17, 2009 Andrew Sullivan	Fear Is Your Friend Warren Buffett is buying because he realizes that you buy stocks for the future, not the present.
The Motley Fool May 3, 2010 Eric Bleeker	3 Tech Stocks Even Buffett Could Love These three tech stocks could melt a hardened value investor's heart.
The Motley Fool July 28, 2005 Rich Duprey	Chiron's Tragic Quarter The biotech vaccine maker barely breaks even but boasts of its ability to meet full-year expectations.
The Motley Fool December 10, 2004 Rich Duprey	Regulators Quarantine Chiron The FDA sends a warning letter on the heels of a suspension extension by British authorities. Whether shares of the pharmaceutical ultimately finish up or down, the one-two punch from U.S. and British authorities still points to an ailing company.
The Motley Fool July 7, 2010 Mac Greer	3 Things People Are Getting Wrong About Warren Buffett Three common misconceptions about the Oracle of Omaha.
The Motley Fool May 13, 2009 Anand Chokkavelu	Everything We Learned From Buffett and Munger Warren Buffett and Charlie Munger break down the current financial crisis and expound on their investing philosophies.
The Motley Fool April 25, 2008 Hanson & Richards	Warren Buffett Is a Better Investor Than You Investing advice from Warren Buffett's business partner Charlie Munger.
The Motley Fool September 21, 2007 Sham Gad	Buffett's Equity Investment Strategy: Part 2 Investing gurus Warren Buffett and Charlie Munger explain how they define "value" and "growth" companies.
The Motley Fool August 8, 2005 Chuck Saletta	Investing's Afterburner Buying and holding companies on sale can turbocharge your returns.
The Motley Fool March 3, 2005 Rich Duprey	Chiron Back From the Dead British authorities give vaccine manufacturer the go-ahead to restart facility. Investors can breathe a sigh of relief.
The Motley Fool August 3, 2007 Rich Duprey	The Only 3 Ideas You Need Instead of buying insanely valued stocks at a premium, we should be looking at deeply discounted stocks that the market has tossed aside.
The Motley Fool October 21, 2008 Andy Louis-Charles	Is Now A Good Time for the S&P? The S&P 500 has recently fallen to levels unseen since the start of the Iraq War in 2003. The question is, are investors better or worse off owning it?
The Motley Fool April 7, 2004 Gardner & Moore	Small Stocks, Big Gains Here's the philosophy behind the successful Hidden Gems investing strategy.
The Motley Fool July 5, 2006 Rich Duprey	Flu Vaccine Deja Vu The country's largest vaccine maker, Sanofi Aventis, gets an FDA warning letter reminiscent of the 2004 debacle.
The Motley Fool May 12, 2005 Bill Mann	What Every Great Investor Must Have Successful investing requires intelligence, knowledge, curiosity, and something else besides money. That's where the discipline comes in. If you can stomach the fact that you will make good decisions but the market will routinely disagree in the short term, you can make a lot of money.
The Motley Fool May 27, 2005 Rich Duprey	Glaxo's Flu Vaccine Booster The drug giant's return could give the U.S. flu vaccine market a shot in the arm.
The Motley Fool July 19, 2005 Seth Jayson	Simple Ways to Whip the Experts Beating Wall Street is simple -- if you look for value.
The Motley Fool October 31, 2005 Rich Duprey	Chiron Not Immune to Merger The board accepts a sweetened buyout offer from Swiss pharmaceutical firm Novartis. Investors, take note.
The Motley Fool October 14, 2005 Rich Duprey	Chiron Ready to Fly Flu vaccine maker readies first shipments as flu season begins and avian flu fears rise.
The Motley Fool May 22, 2008 Dan Caplinger	What Warren Buffett Can't Teach You Your investing success depends on you.
The Motley Fool November 1, 2008 Jim Mueller	Buffett Says It's Time to "Be Greedy" When sentiment is at its worst, it's time to buy.